Do TREM2 activation states define distinct amyloid clearance thresholds requiring personalized dosing strategies?

OPEN

The debate introduced TREM2-dependent microglial transitions as threshold determinants but left the mechanistic details and clinical implications unresolved. This could explain patient-to-patient variability in treatment response. Source: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-192526-f2bbb9ab_20260416-135142 (Analysis: SDA-2026-04-16-gap-pubmed-20260410-192526-f2bbb9ab)

Priority: 0.79 Domain: immunology Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: Do TREM2 activation states define distinct amyloid clearance thresholds requiring personalized dosing strategies? is a 0.79 priority gap in immunology. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Do TREM2 activation states define distinct amyloid clearance thresholds requiring personalized dosing strategies? — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.00

Avg Quality

Resolution

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (10)

TREM2→AlzheimerTREM2→ALZHEIMER'S DISEASETREM2→NeuroinflammationMICROGLIA→TREM2TREM2→ALZHEIMER

▸ Show 5 more

TREM2→APOETREM2→MICROGLIATREM2→AlsTREM2→InflammationTREM2→NEUROINFLAMMATION

associated with (14)

TREM2→ALZHEIMER'S DISEASETREM2→MICROGLIAALZHEIMER'S DISEASE→TREM2TREM2→neurodegenerationAMYLOID→TREM2

▸ Show 9 more

TREM2→AlzheimerTREM2→NEURODEGENERATIONMICROGLIA→TREM2NEURODEGENERATION→TREM2TREM2→ALZHEIMERSTREM2→GENESTREM2→ALZHEIMERAPOE→TREM2TREM2→Neurodegeneration

data in (8)

ad_genetic_risk_loci:TREM2→TREM2benchmark_ot_ad_answer_key:TREM2→TREM2TREM2→benchmark_ot_ad_answer_key:TREM2ds-db4a006ea647→TREM2ds-f50762b67605→TREM2

▸ Show 3 more

ds-6784494f1741→TREM2ds-f2c28aed24a7→TREM2ds-83b31ef18d49→TREM2

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps

Do TREM2 activation states define distinct amyloid clearance thresholds requiring personalized dosing strategies?

Key Unanswered Questions

Key Researchers

Clinical Trials

Hypothesis Score Distribution

activates (10)

associated with (14)

data in (8)

expressed in (3)

inhibits (1)

provides data for (5)

regulates (2)

relates to (2)

therapeutic target (5)